No worries! CAD risk disclosure OK at Alzheimer’s genotyping

Medscape |
January 2016

Through the REVEAL study, researchers were testing to see how participants anxiety, depression, and test-related distress would be affected by knowing their genetic results of Alzheimer’s Disease and Coronary artery disease.